Entering the North American medical device market requires navigating two highly regulated yet interconnected systems—the U.S. FDA and Health Canada. From medical device registration americas and establishment listing to obtaining Canadian Medical Device Licenses (MDL) and Medical Device Establishment Licenses (MDEL), every step demands precision, planning, and regulatory clarity.

Masuu Global Solutions supports manufacturers, importers, and startups with an integrated U.S.–Canada market access strategy. We interpret requirements, define optimal regulatory pathways, and guide you seamlessly from development to approval and ongoing compliance.

Medical Device Registration in the Americas & Canada

The North American market is one of the largest and most regulated medical device ecosystems in the world.
  • In the United States, device approval and oversight fall under the FDA’s Center for Devices and Radiological Health (CDRH).
  • In Canada, medical devices are governed by Health Canada under a risk based classification system.
Both countries use similar risk based classes, but with variations:
  • U.S.: Class I, II, III
  • Canada: Class I, II, III, IV
Manufacturers must demonstrate safety, effectiveness, and quality through:
  • Strong technical documentation
  • A compliant Quality Management System (QMS) aligned with ISO 13485
  • Programs such as MDSAP, which streamline audits across major markets

Masuu Global Solutions helps unify your U.S. and Canadian regulatory strategy—aligning classification, technical evidence, QMS readiness, and submissions so you can accelerate approvals in both markets using a single, harmonized approach.

Masuu’s Medical Device Registration Services (Americas)

Expertise

  • Regulatory and market intelligence for U.S. and Canada
  • Product classification according to FDA and Health Canada rules
  • U.S. medical device registration: 513(g) assessments and the correct pathway (510(k), De Novo, PMA, IDE)
  • Pre Submission meetings with FDA or Health Canada
  • Support preparing Design History File (DHF) and other product documentation
  • Gap analysis for technical files and Good Manufacturing Practice (GMP) systems
  • Full support for technical file compilation for each required pathway
  • U.S. FDA Quality System compliance strategy (21 CFR 820 / forthcoming QMSR)
  • MDSAP compliance assistance
  • Canada MDL and MDEL application support
  • Liaising directly with regulatory authorities
  • In country representation as U.S. Agent and Canadian Regulatory Representative
  • Post approval support and lifecycle compliance

Advantages of Working With Masuu in the Americas

  • Proven success across all device classes—from SaMD to high risk implantables
  • Local affiliates to meet authority specific, language, and documentation needs
  • A dedicated team specializing in U.S. FDA and Health Canada submissions
  • Cost effective options for U.S. Agent and Canadian regulatory representation
  • Strong track record delivering projects across the U.S. and Canada
  • U.S.-anchored presence for efficient communication and real time support

Why Partner With Masuu Global Solutions?

  • End to end North America regulatory expertise—from submissions to post market surveillance
  • Proven success across 1500+ medical device registrations globally, including U.S. Class I–III and Canada Class I–IV devices
  • On ground support through U.S. Agent services and Canadian representation
  • Integrated U.S.–Canada regulatory strategy to minimize duplication, reduce costs, and shorten timelines
  • Direct engagement with FDA and Health Canada for faster, clearer communication
  • Trusted by 470+ medical device manufacturers—from emerging startups to global leaders

Frequently Asked Questions

Medical device registration in the USA requires manufacturers to determine the appropriate FDA regulatory pathway based on device classification, intended use, and regulatory status. Depending on the device, the process may involve 510(k), De Novo, PMA, IDE, or other applicable requirements, followed by establishment registration and listing where required.

Medical device registration in Canada is handled by Health Canada and depends on the device’s risk classification. Manufacturers may need to obtain a Medical Device Licence (MDL), while certain importers and distributors may require a Medical Device Establishment Licence (MDEL). The applicable requirements depend on the organization’s role and device classification.

FDA and Health Canada use different regulatory frameworks for medical devices. The FDA classifies devices as Class I, II, and III, while Canada uses Classes I through IV. Their submission pathways, licensing requirements, technical documentation, and establishment requirements also differ, so manufacturers need a market-specific strategy for each country.

The appropriate FDA pathway depends on the device’s classification, intended use, technological characteristics, and existing regulatory precedents. Potential pathways include 510(k), De Novo, PMA, and IDE. A 513(g) assessment can also help manufacturers obtain information from the FDA about device classification and applicable regulatory requirements before selecting a pathway.

A Medical Device Licence (MDL) is used for applicable medical devices marketed in Canada, while a Medical Device Establishment Licence (MDEL) applies to certain establishments involved in activities such as importing or distributing medical devices. Whether an MDL or MDEL is required depends on the device classification and the organization’s role in the Canadian market.

Foreign medical device manufacturers may need a U.S. Agent to act as a point of contact with the FDA when entering the U.S. market. The U.S. Agent can facilitate regulatory communications and other required interactions with the FDA. The specific obligations depend on the manufacturer’s location and regulatory status.

Manufacturers located outside Canada may need Canadian regulatory representation depending on their activities and applicable Health Canada requirements. A Canadian representative can support regulatory communication and market-entry activities. Representation requirements should be assessed alongside device classification, licensing obligations, importer responsibilities, and the manufacturer’s intended Canadian distribution model.

Risk classification directly influences the regulatory pathway and evidence required for market entry. The U.S. uses Class I, II, and III, while Canada uses Class I, II, III, and IV. Because classification criteria and regulatory requirements differ between the countries, manufacturers should evaluate classification separately for each market.

A coordinated U.S.–Canada regulatory strategy can help manufacturers align classification, technical documentation, quality-system readiness, and submission planning. However, FDA and Health Canada have different regulatory requirements and pathways. A harmonized strategy can reduce duplication where requirements overlap while still addressing each country’s specific registration and licensing obligations.

Medical device manufacturers entering the U.S. and Canadian markets need appropriate quality management controls supporting product safety, effectiveness, and regulatory compliance. ISO 13485 can provide the QMS framework, while MDSAP can support applicable audit requirements across participating jurisdictions. The specific QMS expectations depend on the device and regulatory pathway.

Book a Demo